preclinical white papers and articles

  1. Collaborating To Support Customers From Discovery Through To Clinical 4/12/2023

    The pharmaceutical industry's siloed structure often leads to inefficient and costly development. Charles River and Quotient Sciences' collaboration offers an integrated approach designed to remove obstacles and reduce timelines.

  2. FDA Introduces 'Nonclinical Tests' Term, Signaling A New Beginning 3/27/2023

    Discover how this terminology change will require the investment of time and resources to deliver its full potential.

  3. Software Opportunities And Challenges In The Life Sciences Industry 8/23/2022

    Robust, low-maintenance integrations between ERP and specialty software can ensure a free flow of data to enable all-round visibility of activities and events in a life sciences company.

  4. Two Technologies That Help Life Sciences Companies Scale For Massive Growth 8/22/2022

    Learn the six reasons that make Coupa and NetSuite a great team for ushering massive growth for life sciences companies. 

  5. Relying On Nonclinical Development Basics For Your Program 8/8/2022

    Enhance the ability to assemble the right experts to implement the best strategy when determining which nonclinical studies are necessary for a program.

  6. Building Quality Into Everything We Do – From A To Z 7/7/2022

    By having better control over our manufacturing processes we are able to minimize the risk of out-of-specification intermediates all the way through to final products.

  7. Innovation Standardized – Bioseparation Methods For Biotherapeutics 7/5/2022

    Discover the most impactful standards in liquid chromatography (LC) for biotherapeutics. The standardizations include methods, columns, standards, and robustness.

  8. Once Your Drug Substance Has Been Manufactured, How Do You Successfully Bridge Into Drug Product Development? 6/8/2022

    After your drug substance has been manufactured, the next challenge is formulating your API with other inactive ingredients (excipients) into a finished dosage form (drug product) for clinical trials.

  9. What Do I Do About Incidental Findings In Research? 5/23/2022

    Find out how incidental findings can result from a standard, approved clinical test or intervention and can also be found from a research test or intervention.

  10. The Clinical Development Plan: Ensuring Success 2/17/2022

    For an early-stage pharma/biotech company, the Clinical Development Plan (CDP) can be extremely valuable and a key indicator of potential success of a program. This white paper highlights key components for developing and executing a clinical research strategy once the plan is in place.